SECTION 303(e)(2) OF THE MMA IMPLEMENTS A SUPPLYING FEE FOR IMMUNOSUPPRESSIVE DRUGS, ORAL ANTI-CANCER CHEMOTHERAPEUTIC DRUGS, AND ANTI-EMETIC DRUGS USED AS PART OF AN ANTI-CANCER CHEMOTHERAPEUTIC REGIMEN.
CMS — ICD-10-PCS FY2026, HCPCS Level II october 2026, Procedure Codes 2026.